nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—Dermatitis bullous—Vandetanib—thyroid cancer	0.0387	0.0387	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Vandetanib—thyroid cancer	0.0292	0.0292	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.0283	0.0283	CcSEcCtD
Nalidixic Acid—Visual impairment—Vandetanib—thyroid cancer	0.0247	0.0247	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Vandetanib—thyroid cancer	0.0242	0.0242	CcSEcCtD
Nalidixic Acid—Optic neuritis—Epirubicin—thyroid cancer	0.0207	0.0207	CcSEcCtD
Nalidixic Acid—Convulsion—Vandetanib—thyroid cancer	0.0193	0.0193	CcSEcCtD
Nalidixic Acid—Optic neuritis—Doxorubicin—thyroid cancer	0.0191	0.0191	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.0191	0.0191	CcSEcCtD
Nalidixic Acid—Arthralgia—Vandetanib—thyroid cancer	0.019	0.019	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Sorafenib—thyroid cancer	0.0189	0.0189	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Vandetanib—thyroid cancer	0.0178	0.0178	CcSEcCtD
Nalidixic Acid—Blister—Epirubicin—thyroid cancer	0.0176	0.0176	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.0166	0.0166	CcSEcCtD
Nalidixic Acid—Paraesthesia—Vandetanib—thyroid cancer	0.0163	0.0163	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Sorafenib—thyroid cancer	0.0163	0.0163	CcSEcCtD
Nalidixic Acid—Blister—Doxorubicin—thyroid cancer	0.0163	0.0163	CcSEcCtD
Nalidixic Acid—Erythema—Sorafenib—thyroid cancer	0.015	0.015	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0149	0.0149	CcSEcCtD
Nalidixic Acid—Abdominal pain—Vandetanib—thyroid cancer	0.0144	0.0144	CcSEcCtD
Nalidixic Acid—Angioedema—Sorafenib—thyroid cancer	0.0137	0.0137	CcSEcCtD
Nalidixic Acid—Leukopenia—Sorafenib—thyroid cancer	0.0135	0.0135	CcSEcCtD
Nalidixic Acid—Asthenia—Vandetanib—thyroid cancer	0.013	0.013	CcSEcCtD
Nalidixic Acid—Pruritus—Vandetanib—thyroid cancer	0.0129	0.0129	CcSEcCtD
Nalidixic Acid—Arthralgia—Sorafenib—thyroid cancer	0.0128	0.0128	CcSEcCtD
Nalidixic Acid—Diarrhoea—Vandetanib—thyroid cancer	0.0124	0.0124	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Sorafenib—thyroid cancer	0.0123	0.0123	CcSEcCtD
Nalidixic Acid—Dizziness—Vandetanib—thyroid cancer	0.012	0.012	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Sorafenib—thyroid cancer	0.012	0.012	CcSEcCtD
Nalidixic Acid—Vomiting—Vandetanib—thyroid cancer	0.0116	0.0116	CcSEcCtD
Nalidixic Acid—Rash—Vandetanib—thyroid cancer	0.0115	0.0115	CcSEcCtD
Nalidixic Acid—Dermatitis—Vandetanib—thyroid cancer	0.0115	0.0115	CcSEcCtD
Nalidixic Acid—Headache—Vandetanib—thyroid cancer	0.0114	0.0114	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.0112	0.0112	CcSEcCtD
Nalidixic Acid—Nausea—Vandetanib—thyroid cancer	0.0108	0.0108	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Sorafenib—thyroid cancer	0.01	0.01	CcSEcCtD
Nalidixic Acid—Urticaria—Sorafenib—thyroid cancer	0.00975	0.00975	CcSEcCtD
Nalidixic Acid—Abdominal pain—Sorafenib—thyroid cancer	0.0097	0.0097	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Epirubicin—thyroid cancer	0.00965	0.00965	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00953	0.00953	CcSEcCtD
Nalidixic Acid—Diplopia—Epirubicin—thyroid cancer	0.00922	0.00922	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00893	0.00893	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00882	0.00882	CcSEcCtD
Nalidixic Acid—Asthenia—Sorafenib—thyroid cancer	0.0088	0.0088	CcSEcCtD
Nalidixic Acid—Pruritus—Sorafenib—thyroid cancer	0.00868	0.00868	CcSEcCtD
Nalidixic Acid—Diplopia—Doxorubicin—thyroid cancer	0.00854	0.00854	CcSEcCtD
Nalidixic Acid—Diarrhoea—Sorafenib—thyroid cancer	0.00839	0.00839	CcSEcCtD
Nalidixic Acid—Dizziness—Sorafenib—thyroid cancer	0.00811	0.00811	CcSEcCtD
Nalidixic Acid—Eosinophilia—Epirubicin—thyroid cancer	0.00789	0.00789	CcSEcCtD
Nalidixic Acid—Vomiting—Sorafenib—thyroid cancer	0.0078	0.0078	CcSEcCtD
Nalidixic Acid—Rash—Sorafenib—thyroid cancer	0.00774	0.00774	CcSEcCtD
Nalidixic Acid—Dermatitis—Sorafenib—thyroid cancer	0.00773	0.00773	CcSEcCtD
Nalidixic Acid—Headache—Sorafenib—thyroid cancer	0.00769	0.00769	CcSEcCtD
Nalidixic Acid—Eosinophilia—Doxorubicin—thyroid cancer	0.0073	0.0073	CcSEcCtD
Nalidixic Acid—Nausea—Sorafenib—thyroid cancer	0.00729	0.00729	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00728	0.00728	CcSEcCtD
Nalidixic Acid—Drowsiness—Epirubicin—thyroid cancer	0.00711	0.00711	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00705	0.00705	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00697	0.00697	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00673	0.00673	CcSEcCtD
Nalidixic Acid—Drowsiness—Doxorubicin—thyroid cancer	0.00658	0.00658	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00652	0.00652	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00645	0.00645	CcSEcCtD
Nalidixic Acid—Visual impairment—Epirubicin—thyroid cancer	0.00615	0.00615	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Epirubicin—thyroid cancer	0.00603	0.00603	CcSEcCtD
Nalidixic Acid—Visual impairment—Doxorubicin—thyroid cancer	0.00569	0.00569	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Doxorubicin—thyroid cancer	0.00558	0.00558	CcSEcCtD
Nalidixic Acid—Erythema—Epirubicin—thyroid cancer	0.00556	0.00556	CcSEcCtD
Nalidixic Acid—Erythema—Doxorubicin—thyroid cancer	0.00514	0.00514	CcSEcCtD
Nalidixic Acid—Vertigo—Epirubicin—thyroid cancer	0.00499	0.00499	CcSEcCtD
Nalidixic Acid—Leukopenia—Epirubicin—thyroid cancer	0.00497	0.00497	CcSEcCtD
Nalidixic Acid—Convulsion—Epirubicin—thyroid cancer	0.00481	0.00481	CcSEcCtD
Nalidixic Acid—Arthralgia—Epirubicin—thyroid cancer	0.00473	0.00473	CcSEcCtD
Nalidixic Acid—Vertigo—Doxorubicin—thyroid cancer	0.00462	0.00462	CcSEcCtD
Nalidixic Acid—Leukopenia—Doxorubicin—thyroid cancer	0.0046	0.0046	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Epirubicin—thyroid cancer	0.00453	0.00453	CcSEcCtD
Nalidixic Acid—Convulsion—Doxorubicin—thyroid cancer	0.00445	0.00445	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Epirubicin—thyroid cancer	0.00444	0.00444	CcSEcCtD
Nalidixic Acid—Arthralgia—Doxorubicin—thyroid cancer	0.00438	0.00438	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Doxorubicin—thyroid cancer	0.0042	0.0042	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00413	0.00413	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00411	0.00411	CcSEcCtD
Nalidixic Acid—Paraesthesia—Epirubicin—thyroid cancer	0.00407	0.00407	CcSEcCtD
Nalidixic Acid—Somnolence—Epirubicin—thyroid cancer	0.00403	0.00403	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00382	0.00382	CcSEcCtD
Nalidixic Acid—Paraesthesia—Doxorubicin—thyroid cancer	0.00377	0.00377	CcSEcCtD
Nalidixic Acid—Somnolence—Doxorubicin—thyroid cancer	0.00373	0.00373	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00371	0.00371	CcSEcCtD
Nalidixic Acid—Urticaria—Epirubicin—thyroid cancer	0.0036	0.0036	CcSEcCtD
Nalidixic Acid—Abdominal pain—Epirubicin—thyroid cancer	0.00358	0.00358	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00343	0.00343	CcSEcCtD
Nalidixic Acid—Urticaria—Doxorubicin—thyroid cancer	0.00333	0.00333	CcSEcCtD
Nalidixic Acid—Abdominal pain—Doxorubicin—thyroid cancer	0.00332	0.00332	CcSEcCtD
Nalidixic Acid—Asthenia—Epirubicin—thyroid cancer	0.00325	0.00325	CcSEcCtD
Nalidixic Acid—Pruritus—Epirubicin—thyroid cancer	0.00321	0.00321	CcSEcCtD
Nalidixic Acid—Diarrhoea—Epirubicin—thyroid cancer	0.0031	0.0031	CcSEcCtD
Nalidixic Acid—Asthenia—Doxorubicin—thyroid cancer	0.00301	0.00301	CcSEcCtD
Nalidixic Acid—Dizziness—Epirubicin—thyroid cancer	0.003	0.003	CcSEcCtD
Nalidixic Acid—Pruritus—Doxorubicin—thyroid cancer	0.00297	0.00297	CcSEcCtD
Nalidixic Acid—Vomiting—Epirubicin—thyroid cancer	0.00288	0.00288	CcSEcCtD
Nalidixic Acid—Diarrhoea—Doxorubicin—thyroid cancer	0.00287	0.00287	CcSEcCtD
Nalidixic Acid—Rash—Epirubicin—thyroid cancer	0.00286	0.00286	CcSEcCtD
Nalidixic Acid—Dermatitis—Epirubicin—thyroid cancer	0.00286	0.00286	CcSEcCtD
Nalidixic Acid—Headache—Epirubicin—thyroid cancer	0.00284	0.00284	CcSEcCtD
Nalidixic Acid—Dizziness—Doxorubicin—thyroid cancer	0.00277	0.00277	CcSEcCtD
Nalidixic Acid—Nausea—Epirubicin—thyroid cancer	0.00269	0.00269	CcSEcCtD
Nalidixic Acid—Vomiting—Doxorubicin—thyroid cancer	0.00267	0.00267	CcSEcCtD
Nalidixic Acid—Rash—Doxorubicin—thyroid cancer	0.00265	0.00265	CcSEcCtD
Nalidixic Acid—Dermatitis—Doxorubicin—thyroid cancer	0.00264	0.00264	CcSEcCtD
Nalidixic Acid—Headache—Doxorubicin—thyroid cancer	0.00263	0.00263	CcSEcCtD
Nalidixic Acid—Nausea—Doxorubicin—thyroid cancer	0.00249	0.00249	CcSEcCtD
